Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
1.260
-0.020 (-1.56%)
Mar 7, 2025, 4:00 PM EST - Market closed
Zura Bio Employees
As of December 31, 2023, Zura Bio had 15 total employees, including 14 full-time and 1 part-time employees.
Employees
15
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,841,067
Market Cap
82.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15 | - | - |
ZURA News
- 12 days ago - Zura Bio to Present at the Leerink Partners Global Healthcare Conference - Business Wire
- 2 months ago - Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis - Business Wire
- 3 months ago - Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 4 months ago - Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Business Wire
- 4 months ago - Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire
- 4 months ago - Zura Bio to Participate in Two Upcoming Investor Conferences in November - Business Wire
- 6 months ago - CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology - Business Wire
- 6 months ago - Zura Bio to Present at Three Upcoming Investor Conferences in September - Business Wire